Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Item
http://www.wikidata.org/entity/Q33863802
Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancerPhase I/II clinical trial of encapsulated, cytochrome P450 expressing cells as local activators of cyclophosphamide to treat spontaneous canine tumours.A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride).Cytochrome P450-based cancer gene therapy: current status.Tumor-activated prodrugs--a new approach to cancer therapy.Suicide gene therapy for graft-versus-host disease.Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice.Isolation of human foetal myoblasts and its application for microencapsulation.Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system.Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation.Microfluidic-Based Synthesis of Hydrogel Particles for Cell Microencapsulation and Cell-Based Drug Delivery
P2860

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.

Item
http://www.wikidata.org/entity/Q33863802
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@ast
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@en
type
label
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@ast
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@en
prefLabel
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@ast
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Cell therapy using microencaps ...... carcinoma: a phase I/II study.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698